Inflammatory and endothelial activation biomarkers and risk of sepsis: A nested case-control study

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 549-555

  Wang, Henry E ^a   Shapiro, Nathan I ^b   Griffin, Russell ^c   Safford, Monika M ^d   Judd, Suzanne ^c   Howard, George ^c  

^a University of Alabama at Birmingham Heersink School of Medicine   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Biomarkers; Endothelium; Infections; Inflammation; Sepsis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; CELL ACTIVATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGNOSIS; SEPSIS; SMOKING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOMARKERS; ENDOTHELIUM; INFECTIONS; INFLAMMATION; SEPSIS;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION; MALE; RISK; RISK ASSESSMENT; SEPSIS; UNITED STATES;

EID: 84883556246     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.11.002     Document Type: Article

References (18)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
2. Wang H.E., Shapiro N.I., Angus D.C., Yealy D.M. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007, 35(8):1928-1936.
3. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Eng J Med 2003, 348(16):1546-1554.
4. Kellum J.A., Kong L., Fink M.P., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167(15):1655-1663.
5. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101(10):3765-3777.
6. Aird W.C. Endothelium as a therapeutic target in sepsis. Curr Drug Targets 2007, 8(4):501-507.
7. Shapiro N.I., Schuetz P., Yano K., et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010, 14(5).
8. Howard V.J., Cushman M., Pulley L., et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005, 25(3):135-143.
9. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29(4):530-538.
10. Yende S., Tuomanen E.I., Wunderink R., et al. Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med 2005, 172(11):1440-1446.
11. National Institute on Alcohol Abuse and Alcoholism Helping patients who drink too much, a clinician's guide Accessed February 13, 2012. http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf.
12. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612.
13. Sunyer J., Forastiere F., Pekkanen J., et al. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res 2009, 11(11):1347-1353.
14. Hwang S.J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997, 96(12):4219-4225.
15. Marshall J.C., Reinhart K. Biomarkers of sepsis. Crit Care Med 2009, 37(7):2290-2298.
16. Sutherland A.M., Walley K.R. Bench-to-bedside review: association of genetic variation with sepsis. Crit Care 2009, 13(2):210.
17. Teoh H., Quan A., Creighton A.K., et al. BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Gene Ther 2012.
18. Povoa P., Almeida E., Moreira P., et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998, 24(10):1052-1056.